Variables | Patients | miR-106a-5p expression | χ2 | P value | |
---|---|---|---|---|---|
(n = 104) | High (n = 52) | Low (n = 52) | |||
Gender | Â | Â | Â | 0.979 | 0.322 |
 Male | 59 | 27 (51.9) | 32 (61.5) |  |  |
 Female | 45 | 25 (48.1) | 20 (38.5) |  |  |
Age (years) | Â | Â | Â | 3.126 | 0.077 |
 ≤ 60 | 49 | 20 (38.5) | 29 (55.8) |  |  |
 > 60 | 55 | 32 (61.5) | 23 (44.2) |  |  |
Tumor location | Â | Â | Â | 1.418 | 0.234 |
 Colon | 44 | 19 (36.5) | 25 (48.1) |  |  |
 Rectum | 60 | 33 (63.5) | 27 (51.9) |  |  |
Tumor diameter (cm) | Â | Â | Â | 2.719 | 0.099 |
 ≤ 5 | 68 | 30 (57.7) | 38 (73.1) |  |  |
 > 5 | 36 | 22 (42.3) | 14 (26.9) |  |  |
Tumor differentiation | Â | Â | Â | 4.872 | 0.027 |
 Poor | 41 | 26 (50.0) | 15 (28.8) |  |  |
 Well / Moderate | 63 | 26 (50.0) | 37 (71.2) |  |  |
pT stage | Â | Â | Â | 1.846 | 0.174 |
 T1-2 | 26 | 16 (30.8) | 10 (19.2) |  |  |
 T3-4 | 78 | 36 (69.2) | 42 (80.8) |  |  |
pN stage | Â | Â | Â | 0.038 | 0.844 |
 N0 | 51 | 26 (50.0) | 25 (48.1) |  |  |
 N1-2 | 53 | 26 (50.0) | 27 (51.9) |  |  |
Distant metastasis | Â | Â | Â | 4.265 | 0.039 |
 M0 | 79 | 35 (67.3) | 44 (84.6) |  |  |
 M1 | 25 | 17 (32.7) | 8 (15.4) |  |  |
pTNM stage | Â | Â | Â | 0.639 | 0.424 |
 I-II | 42 | 19 (36.5) | 23 (44.2) |  |  |
 III-IV | 62 | 33 (63.5) | 29 (55.8) |  |  |
CEA (ng/ml) | Â | Â | Â | 2.556 | 0.110 |
 ≤ 5 | 62 | 27 (51.9) | 35 (67.3) |  |  |
 > 5 | 42 | 25 (48.1) | 17 (32.7) |  |  |
CA19-9 (U/ml) # | Â | Â | Â | 1.049 | 0.306 |
 ≤ 27 | 67 | 31 (59.6) | 36 (69.2) |  |  |
 > 27 | 37 | 21 (40.4) | 16 (30.8) |  |  |
Lymphatic/microvascular/perineural invasion | Â | Â | Â | 7.278 | 0.007 |
 Yes | 35 | 24 (46.2) | 11 (21.2) |  |  |
 No | 69 | 28 (53.8) | 41 (78.8) |  |  |